Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William A See

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Urologic Oncology|December 10, 2014
Commentary on "Optimal schedule of bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: A meta-analysis of comparative studies." Zhu S, Tang Y, Li K, Shang Z, Jiang N, Nian X, Sun L, Niu Y, Department of Urology Tianjin Institute of Urology, 2nd Hospital of Tianjin Medical University, People's Republic of China.: BMC Cancer 2013; 13:332. doi:10.1186/1471-2407-13-332William A See
Reviews in Urology|September 21, 2006
Bicalutamide adjuvant to radical prostatectomyWilliam A See
European Urology|April 4, 2012
Words of wisdom. Re: Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trialsWilliam A See
Urologic Oncology|June 26, 2013
Commentary on "Plasma carotenoids and vitamin C concentrations and risk of urothelial cell carcinoma in the European Prospective Investigation into Cancer and Nutrition." Ros MM, Bueno de Mesquita HB, Kampman E, Aben KK, Büchner FL, Jansen EH, van Gils CH, Egevad L, Overvad K, Tjønneland A, Roswall N, Boutron Ruault MC, Kvaskoff M, Perquier F, Kaaks R, Chang Claude J, Weikert S, Boeing H, Trichopoulou A, Lagiou P, Dilis V, Palli D, Pala V, Sacerdote C, Tumino R, Panico S, Peeters PH, Gram IT, Skeie G, Huerta JM, Barricarte A, Quirós JR, Sánchez MJ, Buckland G, Larrañaga N, Ehrnström R, Wallström P, Ljungberg B, Hallmans G, Key TJ, Allen NE, Khaw KT, Wareham N, Brennan P, Riboli E, Kiemeney LA, National Institute for Public Health and the Environment, Bilthoven, Netherlands: Am J Clin Nutr 2012;96(4):902-10 [Epub 2012 Sep 5]William A See
Urologic Oncology|June 26, 2013
Commentary on "The value of transurethral bladder biopsy after intravesical bacillus Calmette-Guérin instillation therapy for nonmuscle invasive bladder cancer: a retrospective, single center study and cumulative analysis of the literature." Swietek N, Waldert M, Rom M, Schatzl G, Wiener HG, Susani M, Klatte T. Department of Urology, Medical University of Vienna, Vienna, Austria: J Urol 2012;188(3):748-53 [Epub 2012 Jul 20]William A See
The Journal of Urology|August 25, 2010
Re: Comparative effectiveness of prostate cancer surgical treatments: a population based analysis of postoperative outcomes: W. T. Lowrance, E. B. Elkin, L. M. Jacks, D. S. Yee, T. L. Jang, V. P. Laudone, B. D. Guillonneau, P. T. Scardino and J. A. Eastham J Urol 2010; 183: 1366-1372William A See
European Urology|December 3, 2013
Re: use of advanced treatment technologies among men at low risk of dying from prostate cancerWilliam A See
Urologic Oncology|August 6, 2013
A manpower calculus: the implications of SUO fellowship expansion on oncologic surgeon case volumesWilliam A See
Urologic Oncology|December 10, 2014
Commentary on "Outpatient laser ablation of non-muscle-invasive bladder cancer: is it safe, tolerable and cost-effective?" Wong KA, Zisengwe G, Athanasiou T, O'Brien T, Thomas K, The Urology Centre, Guys and St. Thomas' NHS Foundation Trust.: BJU Int 2013; 112(5):561-7. doi:10.1111/bju.12216. [Epub 2013 Jul 2]William A See
Current Treatment Options in Oncology|August 28, 2003
Adjuvant hormone therapy after radiation or surgery for localized or locally advanced prostate cancerWilliam A See
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Urologic Oncology|December 10, 2014
Commentary on "Optimal schedule of bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: A meta-analysis of comparative studies." Zhu S, Tang Y, Li K, Shang Z, Jiang N, Nian X, Sun L, Niu Y, Department of Urology Tianjin Institute of Urology, 2nd Hospital of Tianjin Medical University, People's Republic of China.: BMC Cancer 2013; 13:332. doi:10.1186/1471-2407-13-332William A See
Reviews in Urology|September 21, 2006
Bicalutamide adjuvant to radical prostatectomyWilliam A See
European Urology|April 4, 2012
Words of wisdom. Re: Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trialsWilliam A See
Urologic Oncology|June 26, 2013
Commentary on "Plasma carotenoids and vitamin C concentrations and risk of urothelial cell carcinoma in the European Prospective Investigation into Cancer and Nutrition." Ros MM, Bueno de Mesquita HB, Kampman E, Aben KK, Büchner FL, Jansen EH, van Gils CH, Egevad L, Overvad K, Tjønneland A, Roswall N, Boutron Ruault MC, Kvaskoff M, Perquier F, Kaaks R, Chang Claude J, Weikert S, Boeing H, Trichopoulou A, Lagiou P, Dilis V, Palli D, Pala V, Sacerdote C, Tumino R, Panico S, Peeters PH, Gram IT, Skeie G, Huerta JM, Barricarte A, Quirós JR, Sánchez MJ, Buckland G, Larrañaga N, Ehrnström R, Wallström P, Ljungberg B, Hallmans G, Key TJ, Allen NE, Khaw KT, Wareham N, Brennan P, Riboli E, Kiemeney LA, National Institute for Public Health and the Environment, Bilthoven, Netherlands: Am J Clin Nutr 2012;96(4):902-10 [Epub 2012 Sep 5]William A See
Urologic Oncology|June 26, 2013
Commentary on "The value of transurethral bladder biopsy after intravesical bacillus Calmette-Guérin instillation therapy for nonmuscle invasive bladder cancer: a retrospective, single center study and cumulative analysis of the literature." Swietek N, Waldert M, Rom M, Schatzl G, Wiener HG, Susani M, Klatte T. Department of Urology, Medical University of Vienna, Vienna, Austria: J Urol 2012;188(3):748-53 [Epub 2012 Jul 20]William A See
The Journal of Urology|August 25, 2010
Re: Comparative effectiveness of prostate cancer surgical treatments: a population based analysis of postoperative outcomes: W. T. Lowrance, E. B. Elkin, L. M. Jacks, D. S. Yee, T. L. Jang, V. P. Laudone, B. D. Guillonneau, P. T. Scardino and J. A. Eastham J Urol 2010; 183: 1366-1372William A See
European Urology|December 3, 2013
Re: use of advanced treatment technologies among men at low risk of dying from prostate cancerWilliam A See
Urologic Oncology|August 6, 2013
A manpower calculus: the implications of SUO fellowship expansion on oncologic surgeon case volumesWilliam A See
Urologic Oncology|December 10, 2014
Commentary on "Outpatient laser ablation of non-muscle-invasive bladder cancer: is it safe, tolerable and cost-effective?" Wong KA, Zisengwe G, Athanasiou T, O'Brien T, Thomas K, The Urology Centre, Guys and St. Thomas' NHS Foundation Trust.: BJU Int 2013; 112(5):561-7. doi:10.1111/bju.12216. [Epub 2013 Jul 2]William A See
Current Treatment Options in Oncology|August 28, 2003
Adjuvant hormone therapy after radiation or surgery for localized or locally advanced prostate cancerWilliam A See
Pageof 8